Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase IV, Double Blind, Randomized, Study Between Probiatop and Placebo for the Assessment of Improving the Gastrointestinal Function and Intestinal Bacterial Flora in Constipated Patients

NCT03103958 is registered in ClinicalTrials.gov with Farmoquimica S.A. as lead sponsor.

NCT NCT03103958
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03103958 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase IV, Double Blind, Randomized, Study Between Probiatop and Placebo for the Assessment of Improving the Gastrointestinal Function and Intestinal Bacterial Flora in Constipated Patients
Lead sponsor
Farmoquimica S.A.
Phase
Not applicable
Overall status
Completed
Start date
June 28, 2016
Completion date
September 6, 2016
Enrollment
120 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

constipation, intestinal bacteria flora disturbance